Lupin gets USFDA nod for generic cystic fibrosis treatment medicine
India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and Industry Minister Piyush Goyal said on Thursday.
Pharmabiz15d
Lupin’s ivacaftor oral granules receives US FDA tentative approval
Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...
Drug Store News10d
FDA gives Lupin tentative OK for 2 generics
The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...
Drug Store News8d
Lupin launches generic Minzoya
Lupin is introducing Minzoya (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets), 0.1 mg/0.02 mg and 36.5 mg, which is a generic of Avion’s Balcoltra. Generic Minzoya ...
Medscape3d
Novel Once-Daily Cystic Fibrosis Treatment Matches Standard Therapy in Phase 3 Trials
Vanzacaftor-tezacaftor-deutivacaftor, a novel therapeutic, once-daily drug, demonstrates noninferiority to elexacaftor-tezacaftor-ivacaftor (the twice-daily, standard-of-care drug) in lung ...
Business Wire1mon
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA ® (elexacaftor ...
Zee Business15d
Lupin gets USFDA nod for generic cystic fibrosis treatment medicine
The approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Ivacaftor oral granules of strengths 25 mg, 50 mg, and 75 mg per unit dose packet, ...